Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer

NCT02018458 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: LA TNBC: DC vaccine+Preop chemo
BIOLOGICAL: ER+/HER2-BC:DC vaccine+Preop chemo

Sponsor

Baylor Research Institute